SCHEMBL286593

SCHEMBL286593

C=Cc1cc2c(c(OC)c1)C(=O)OC2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
LMNA P02545 3/20 0.49
CYP3A4 P08684 1/20 0.49
PDE5A O76074 1/20 0.48
PDE4A P27815 1/20 0.48
PDE1A P54750 1/20 0.48
PDE1B Q01064 1/20 0.48
PDE4B Q07343 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48
PDE3B Q13370 1/20 0.48
PDE1C Q14123 1/20 0.48
PDE3A Q14432 1/20 0.48
GAA P10253 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MAPT P10636 6/20 0.46
HTT P42858 5/20 0.46
HPGD P15428 2/20 0.42
IMPDH2 P12268 2/20 0.41
TRPA1 O75762 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL286747 0.78 CYP3A4 (0.51) KDM4ELMNACYP3A4PDE5APDE4A
SCHEMBL286734 0.78 KDM4E (0.36) KDM4ELMNACYP3A4PDE5APDE4A
SCHEMBL2060122 0.77 KDM4E (0.71) KDM4ELMNACYP3A4PDE5APDE4A
SCHEMBL29434781 0.77 KDM4E (0.71) KDM4ELMNACYP3A4PDE5APDE4A
SCHEMBL31496832 0.76 CYP3A4 (0.53) KDM4ELMNACYP3A4PDE5APDE4A
SCHEMBL20231727 0.76 CYP3A4 (0.53) KDM4ELMNACYP3A4PDE5APDE4A
SCHEMBL286469 0.74 IMPDH2 (0.48) KDM4ELMNACYP3A4PDE5APDE4A
SCHEMBL286641 0.74 KDM4E (0.48) KDM4ELMNACYP3A4PDE5APDE4A
SCHEMBL12151397 0.71 IMPDH2 (0.65) KDM4ELMNACYP3A4PDE5APDE4A
SCHEMBL286768 0.70 KDM4E (0.49) KDM4ELMNACYP3A4PDE5APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2427444-B1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME (US) 2015-12-16 EP disclosed
US-9018211-B2 Inhibitors of the renal outer medullary potassium channel MERCK SHARP & DOHME CORP. (US) 2015-04-28 US disclosed
US-20140142115-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2014-05-22 US disclosed
US-8673920-B2 Inhibitors of the renal outer medullary potassium channel MERCK SHARP & DOHME CORP. (US) 2014-03-18 US disclosed
EP-2427444-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL Merck Sharp & Dohme Corp. (US) 2012-03-14 EP disclosed
WO-2010129379-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2010-11-11 WO disclosed
US-20100286123-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME LLC 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140142115-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL KCNJ11, KCNJ1, KCNJ2 KDM4E 1977/4885LMNA 1188/4885CYP3A4 4249/4885
US-20100286123-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL KCNJ11, KCNJ1, KCNJ2 KDM4E 1977/4885LMNA 1188/4885CYP3A4 4249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.